NHAS
MIRM icon

Novo Holdings A/S’s Mirum Pharmaceuticals MIRM Stock Holding History

Novo Holdings A/S’s Portfolio MIRM Stock Details MIRM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$132M Sell
1,125,000
-200,000
-15% -$20.1M 7.65% 6
2026
Q1 		$122M Buy
1,325,000
+60,972
+5% +$5.74M 9.92% 4
2025
Q4 		$99.8M Hold
1,264,028
– – 7.75% 4
2025
Q3 		$92.7M Sell
1,264,028
-236,027
-16% -$15M 5.97% 4
2025
Q2 		$76.3M Buy
1,500,055
+55
+0% +$2.45K 5.39% 5
2025
Q1 		$67.6M Hold
1,500,000
– – 5.14% 6
2024
Q4 		$62M Hold
1,500,000
– – 3.76% 8
2024
Q3 		$58.5M Hold
1,500,000
– – 2.91% 9
2024
Q2 		$51.3M Hold
1,500,000
– – 2.76% 10
2024
Q1 		$37.7M Hold
1,500,000
– – 2.6% 12
2023
Q4 		$44.3M Hold
1,500,000
– – 2.73% 11
2023
Q3 		$47.4M Sell
1,500,000
-184,193
-11% -$5.04M 3.5% 9
2023
Q2 		$43.6M Hold
1,684,193
– – 3.37% 9
2023
Q1 		$40.5M Hold
1,684,193
– – 2.67% 14
2022
Q4 		$32.8M Hold
1,684,193
– – 2.05% 18
2022
Q3 		$35.4M Sell
1,684,193
-343,131
-17% -$8.26M 1.69% 16
2022
Q2 		$37.9M Sell
2,027,324
-172,676
-8% -$4.07M 1.87% 16
2022
Q1 		$48.4M Sell
2,200,000
-245,147
-10% -$5M 2.56% 12
2021
Q4 		$39M Hold
2,445,147
– – 1.85% 11
2021
Q3 		$48.7M Hold
2,445,147
– – 2.52% 10
2021
Q2 		$42.3M Hold
2,445,147
– – 1.88% 15
2021
Q1 		$48.5M Hold
2,445,147
– – 2% 16
2020
Q4 		$42.7M Hold
2,445,147
– – 1.83% 15
2020
Q3 		$47.1M Hold
2,445,147
– – 2.34% 12
2020
Q2 		$47.6M Hold
2,445,147
– – 3.07% 9
2020
Q1 		$34.2M Hold
2,445,147
– – 2.28% 7
2019
Q4 		$60M Hold
2,445,147
– – 3.86% 5
2019
Q3 		$24.6M Buy
+2,445,147
New +$30M 4.21% 6

Other funds holding MIRM

FLSM
Frazier Life Sciences Management Palo Alto, California $4.59B AUM 237.58% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
William Blair Investment Management
William Blair Investment Management Chicago, Illinois $33.3B AUM 44.76% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Novo Holdings A/S's MIRM Position: Q2 2026 in Review

Novo Holdings A/S reduced its Mirum Pharmaceuticals (MIRM) stake by 15% in Q2 2026, selling an estimated $20.1M and leaving 1,125,000 shares worth $132M. The position accounts for 7.65% of the portfolio, ranked #6.

Novo Holdings A/S first reported a position in MIRM in Q3 2019 and has held it in 28 quarters since. 328 funds tracked by Wall St. Rank hold MIRM as of Q2 2026.

  • Novo Holdings A/S held 1,125,000 shares of Mirum Pharmaceuticals worth $132M as of Q2 2026.
  • Novo Holdings A/S sold 200,000 Mirum Pharmaceuticals shares in Q2 2026, an estimated $20.1M.
  • Mirum Pharmaceuticals made up 7.65% of Novo Holdings A/S's portfolio in Q2 2026, its #6 holding.
  • Novo Holdings A/S first reported a position in Mirum Pharmaceuticals in Q3 2019 and has held it in 28 quarters since.
  • 328 funds tracked by Wall St. Rank held Mirum Pharmaceuticals as of Q2 2026.

Based on Novo Holdings A/S's 13F filing for Q2 2026, filed 14 Aug 2026.